BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28385574)

  • 1. Ouabain promotes partial epithelial to mesenchymal transition (EMT) changes in human autosomal dominant polycystic kidney disease (ADPKD) cells.
    Venugopal J; McDermott J; Sanchez G; Sharma M; Barbosa L; Reif GA; Wallace DP; Blanco G
    Exp Cell Res; 2017 Jun; 355(2):142-152. PubMed ID: 28385574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ouabain binds with high affinity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell proliferation.
    Nguyen AN; Wallace DP; Blanco G
    J Am Soc Nephrol; 2007 Jan; 18(1):46-57. PubMed ID: 17151336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.
    Jansson K; Venugopal J; Sánchez G; Magenheimer BS; Reif GA; Wallace DP; Calvet JP; Blanco G
    J Membr Biol; 2015 Dec; 248(6):1145-57. PubMed ID: 26289599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation.
    Nguyen AN; Jansson K; Sánchez G; Sharma M; Reif GA; Wallace DP; Blanco G
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F897-906. PubMed ID: 21697238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta mediated epithelial-mesenchymal transition in autosomal dominant polycystic kidney disease.
    Chea SW; Lee KB
    Yonsei Med J; 2009 Feb; 50(1):105-11. PubMed ID: 19259356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ouabain enhances renal cyst growth in a slowly progressive mouse model of autosomal dominant polycystic kidney disease.
    Trant J; Sanchez G; McDermott JP; Blanco G
    Am J Physiol Renal Physiol; 2023 Dec; 325(6):F857-F869. PubMed ID: 37823195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
    Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
    Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways.
    Jansson K; Nguyen AN; Magenheimer BS; Reif GA; Aramadhaka LR; Bello-Reuss E; Wallace DP; Calvet JP; Blanco G
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F982-90. PubMed ID: 22859406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ouabain Enhances ADPKD Cell Apoptosis via the Intrinsic Pathway.
    Venugopal J; Blanco G
    Front Physiol; 2016; 7():107. PubMed ID: 27047392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro fluid secretion by epithelium from polycystic kidneys.
    Grantham JJ; Ye M; Gattone VH; Sullivan LP
    J Clin Invest; 1995 Jan; 95(1):195-202. PubMed ID: 7814614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease.
    Togawa H; Nakanishi K; Mukaiyama H; Hama T; Shima Y; Sako M; Miyajima M; Nozu K; Nishii K; Nagao S; Takahashi H; Iijima K; Yoshikawa N
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F511-20. PubMed ID: 21084407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease.
    Kim DY; Woo YM; Lee S; Oh S; Shin Y; Shin JO; Park EY; Ko JY; Lee EJ; Bok J; Yoo KH; Park JH
    FASEB J; 2019 Feb; 33(2):2870-2884. PubMed ID: 30332302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the polycystin-1 C-tail enhances sensitivity of M-1 cells to ouabain.
    Jansson K; Magenheimer BS; Maser RL; Calvet JP; Blanco G
    J Membr Biol; 2013 Jul; 246(7):581-90. PubMed ID: 23784065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
    Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
    Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial cell polarity and disease.
    Wilson PD
    Am J Physiol; 1997 Apr; 272(4 Pt 2):F434-42. PubMed ID: 9140043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.
    Wang JQ; Qin F; Zhu L
    J Int Med Res; 2015 Oct; 43(5):629-38. PubMed ID: 26142394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological analysis of renal cystic epithelia in the Pkd2WS25/- mouse model of ADPKD.
    Thomson RB; Mentone S; Kim R; Earle K; Delpire E; Somlo S; Aronson PS
    Am J Physiol Renal Physiol; 2003 Nov; 285(5):F870-80. PubMed ID: 12851251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
    Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
    Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
    Kang MK; Park SH; Choi YJ; Shin D; Kang YH
    J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the Many Actions of Ouabain: Pro-Cystogenic Effects in Autosomal Dominant Polycystic Kidney Disease.
    Venugopal J; Blanco G
    Molecules; 2017 May; 22(5):. PubMed ID: 28467389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.